Evidence map›Paper›PMID 26786590›Full record

SynthesisScientific reports2016

Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression.

Xianlei Cai, Chen Wang, Wanqi Yu, Wenjie Fan, Shan Wang, Ning Shen, Pengcheng Wu, Xiuyang Li, Fudi Wang

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 10 pooled it
17.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 10 syntheses or guidelines pooled it, 233 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Exposure to Trace Elements and Risk of Skin Cancer: A Systematic Review of Epidemiologic Studies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2019
    Pooled it
  11. Trial
  12. Trial
  13. Selenium-Based Nanoplatforms: An Emerging Theranostic Paradigm for Gynecological Cancers.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  14. Article
  15. Selenium biofortification: integrating one health and sustainability.Journal of the science of food and agriculture · 2026
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xianlei CaiInstitute of Environmental Medicine, Zhejiang University, P.R.China.
Chen WangDepartment of Clinic Medicine, Zhejiang University, Hangzhou, P.R.China.
Wanqi YuDepartment of Epidemiology &Biostatistics, Zhejiang University, Hangzhou, P.R.China.
Wenjie FanDepartment of Epidemiology &Biostatistics, Zhejiang University, Hangzhou, P.R.China.
Shan WangDepartment of Epidemiology &Biostatistics, Zhejiang University, Hangzhou, P.R.China.
Ning ShenDepartment of Clinic Medicine, Zhejiang University, Hangzhou, P.R.China.
Pengcheng WuDepartment of Clinic Medicine, Zhejiang University, Hangzhou, P.R.China.
Xiuyang LiInstitute of Environmental Medicine, Zhejiang University, P.R.China.
Fudi WangDepartment of Toxicology &Nutrition, Zhejiang University, Hangzhou, P.R.China.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to investigate the associations between selenium exposure and cancer risk. We identified 69 studies and applied meta-analysis, meta-regression and dose-response analysis to obtain available evidence. The results indicated that high selenium exposure had a protective effect on cancer risk (pooled OR = 0.78; 95%CI: 0.73-0.83). The results of linear and nonlinear dose-response analysis indicated that high serum/plasma selenium and toenail selenium had the efficacy on cancer prevention. However, we did not find a protective efficacy of selenium supplement. High selenium exposure may have different effects on specific types of cancer. It decreased the risk of breast cancer, lung cancer, esophageal cancer, gastric cancer, and prostate cancer, but it was not associated with colorectal cancer, bladder cancer, and skin cancer.

Indexed as

Environmental ExposureFemaleHumansMaleNailsNeoplasmsOdds RatioRisk AssessmentSeleniumSelenium

Identifiers

PMID26786590
PMCPMC4726178
OpenAlexW2418368830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.